Research Project · Health
A Phase 1 Study of MGY825 in People with Lung Cancer
Memorial Sloan Kettering Cancer Centerwww.mskcc.org (opens in a new tab)Catalog updated
- Amount
- Not listed
- Program type
- Research Project
- Field
- Health
- Eligible career stages
- Not listed
About this program
**Synopsis:**
Memorial Sloan Kettering Cancer Center is offering a Phase 1 clinical trial grant to study the safety and efficacy of MGY825 in individuals with lung cancer. This trial aims to evaluate the potential of MGY825 as a treatment option for lung cancer patients. Eligibility is limited to people diagnosed with lung cancer, with no additional specific criteria provided. There is no deadline or letter of intent requirement, and the opportunity is currently open for participation.
In FundFit
FundFit names the researchers at your institution who match this program, and shows the eligibility rules and the announcement in full.
Ask for a demo of this program The form opens already filled in.